SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-114968
Filing Date
2020-10-14
Accepted
2020-10-14 17:10:46
Documents
48
Period of Report
2020-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2032150d1_10q.htm 10-Q 339861
2 EXHIBIT 3.1 tm2032150d1_ex3-1.htm EX-3.1 268031
3 EXHIBIT 31.1 tm2032150d1_ex31-1.htm EX-31.1 12630
4 EXHIBIT 31.2 tm2032150d1_ex31-2.htm EX-31.2 13537
5 EXHIBIT 32.1 tm2032150d1_ex32-1.htm EX-32.1 5248
6 EXHIBIT 32.2 tm2032150d1_ex32-2.htm EX-32.2 5606
13 GRAPHIC tm2032150d1_ex3-1img01.jpg GRAPHIC 2086
  Complete submission text file 0001104659-20-114968.txt   2726493

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tzacu-20200831.xml EX-101.INS 407211
8 XBRL TAXONOMY EXTENSION SCHEMA tzacu-20200831.xsd EX-101.SCH 30285
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tzacu-20200831_cal.xml EX-101.CAL 19370
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tzacu-20200831_def.xml EX-101.DEF 96050
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tzacu-20200831_lab.xml EX-101.LAB 194923
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tzacu-20200831_pre.xml EX-101.PRE 188874
Mailing Address 250 WEST 55TH STREET NEW YORK NY 10019
Business Address 250 WEST 55TH STREET NEW YORK NY 10019 2127105220
Tenzing Acquisition Corp. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 001-38634 | Film No.: 201239584
SIC: 2834 Pharmaceutical Preparations